BIOMAT Database Logo BIOMAT Database Logo

Humidified nasal continuous positive airway pressure in obstructive sleep apnoea. 2003

A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
WellSleep Sleep Investigation Centre, Wellington School of Medicine and Health Sciences, Wellington South, New Zealand. aneill@wnmeds.ac.nz

Heated humidification of nasal continuous positive airway pressure (nCPAP) reduces upper airway symptoms and improves initial use in obstructive sleep apnoea syndrome (OSAS). The present study aimed to assess the effect of heated humidification of nCPAP on upper airway symptoms and initial use in obstructive sleep apnoea. This study was of a randomised, crossover design. Subjects with polysomnographically confirmed OSAS were randomised to 3 weeks nCPAP treatment with heated humidification (nCPAP-humid) or placebo humidification (nCPAP pl-humid). Objective and subjective nCPAP use, upper airway symptoms, and treatment satisfaction were compared. Thirty seven of 42 patients completed the protocol. nCPAP-humid reduced the frequency of adverse upper airway symptoms. nCPAP use over 3 weeks was greater with nCPAP-humid compared with nCPAP pl-humid. No difference was found between the treatment arms in terms of subjective treatment satisfaction or alertness. Heated humidification of nasal continuous positive airway pressure reduces upper airway symptoms and is associated with a small increase in initial use but not subjective sleepiness or treatment satisfaction. The results support the use of heated humidification as a strategy to reduce side-effects related to continuous positive airway pressure but not routine initial use.

UI MeSH Term Description Entries
D006970 Disorders of Excessive Somnolence Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320) Daytime Sleepiness,Daytime Somnolence,Excessive Daytime Sleepiness,Hypersomnia,Hypersomnolence,Primary Hypersomnia Disorders,Secondary Hypersomnia Disorders,DOES (Disorders of Excessive Somnolence),Excessive Somnolence Disorders,Hypersomnia, Recurrent,Hypersomnolence Disorders,Hypersomnolence Disorders, Primary,Hypersomnolence Disorders, Secondary,Primary Hypersomnolence Disorders,Secondary Hypersomnolence Disorders,DOESs (Disorders of Excessive Somnolence),Daytime Sleepiness, Excessive,Daytime Sleepinesses,Daytime Somnolences,Excessive Daytime Sleepinesses,Excessive Somnolence Disorder,Hypersomnia Disorder, Primary,Hypersomnia Disorder, Secondary,Hypersomnias,Hypersomnolence Disorder,Hypersomnolence Disorder, Primary,Hypersomnolence Disorder, Secondary,Primary Hypersomnia Disorder,Primary Hypersomnolence Disorder,Recurrent Hypersomnia,Recurrent Hypersomnias,Secondary Hypersomnia Disorder,Secondary Hypersomnolence Disorder,Sleepiness, Daytime,Sleepiness, Excessive Daytime,Somnolence Disorder, Excessive,Somnolence, Daytime
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006813 Humidity A measure of the amount of WATER VAPOR in the air. Humidities
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea.
May 2005, Thorax,
A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke.
October 2001, The European respiratory journal,
A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
The use of nasal continuous positive airway pressure to treat obstructive sleep apnoea.
November 2002, Archives of disease in childhood,
A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
Severe obstructive sleep apnoea treated with long term nasal continuous positive airway pressure.
January 1985, Thorax,
A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
Five-year effects of nasal continuous positive airway pressure in obstructive sleep apnoea syndrome.
November 1997, The European respiratory journal,
A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
Nasopharyngeal symptoms and nasal continuous positive airway pressure therapy in obstructive sleep apnoea syndrome.
January 1999, Acta oto-laryngologica,
A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
Right ventricular dysfunction in obstructive sleep apnoea: reversal with nasal continuous positive airway pressure.
May 1996, The European respiratory journal,
A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea.
October 1995, Thorax,
A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
Is (re)titration of nasal continuous positive airway pressure for obstructive sleep apnoea necessary?
September 2001, Sleep medicine,
A M Neill, and H S Wai, and S P T Bannan, and C R Beasley, and M Weatherall, and A J Campbell
Required levels of nasal continuous positive airway pressure during treatment of obstructive sleep apnoea.
October 1994, The European respiratory journal,
Copied contents to your clipboard!